Using 5 Alpha Reductase Inhibitors Safely: What Primary Care Physicians Need to Know

November 2024 in “ Journal of Family Medicine and Primary Care ”

Senthil Meenrajan

5 alpha reductase inhibitors androgenetic alopecia hirsutism benign prostatic hypertrophy ARIs

5 Alpha Reductase Inhibitors (ARIs) are commonly used for conditions like benign prostatic hypertrophy, androgenetic alopecia, and hirsutism. Although they are generally safe, ARIs can cause side effects that may persist even after stopping the medication. This review aims to inform primary care physicians about these common side effects, emphasizing the importance of considering ARIs as a potential cause of new symptoms in patients. This awareness is crucial for accurate diagnosis and management of adverse drug reactions related to ARIs.

View this study on journals.lww.com →

Discuss this study in the Community →

Research cited in this study

9 / 9 results

research 5-Alpha Reductase Inhibitors Use in Prostatic Disease and Beyond

March 2023 in “Translational Andrology and Urology”

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

research Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide

December 2022 in “JAMA network open”

5α-Reductase inhibitors may increase depression risk but not dementia or suicide.

research Post-Finasteride Syndrome: Risks and Side Effects of Finasteride for Androgenetic Alopecia

15 citations, March 2020 in “Anais Brasileiros De Dermatologia”

Finasteride may cause lasting sexual, mental, and physical symptoms; use with caution.

research Post-Finasteride Syndrome: A Surmountable Challenge for Clinicians

30 citations, January 2020 in “Fertility and Sterility”

Finasteride can cause serious side effects in some men, needing more research for treatment.

research Risk of Rhabdomyolysis from 5-Alpha Reductase Inhibitors

6 citations, January 2018 in “Pharmacoepidemiology and Drug Safety”

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

research The Risk of Dementia with the Use of 5 Alpha Reductase Inhibitors

18 citations, June 2017 in “Journal of the neurological sciences”

Using 5 alpha reductase inhibitors may increase dementia risk in the first two years.

research Effect of 5α-Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Review of Randomized Controlled Trials

57 citations, July 2016 in “The Journal of Sexual Medicine”

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

research Finasteride-Induced Myalgia and HyperCKemia

10 citations, December 2008 in “Journal of Clinical Neuromuscular Disease”

Finasteride can cause muscle pain and high creatine kinase levels, but stopping the medication may resolve symptoms.

research Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor

408 citations, May 2004 in “The Journal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism”

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Related Community Posts Join

6 / 1000+ results

community Spironolactone for 11 years, finasteride for almost 5 years, started oral minoxidil in November 😢 ended oral contraceptive in Dec.

in Progress Pictures 224 upvotes 7 months ago

A user shared their 11-year experience with spironolactone and nearly 5 years with finasteride for hair loss, recently adding oral minoxidil and stopping birth control. Various treatments were discussed, including organic options, checking for underlying health issues, considering dutasteride, and the potential role of progesterone in hair loss.

community Hair Loss Drugs Ranked in Order of Efficacy

in Research/Science 67 upvotes 11 months ago

Dutasteride is likely the most effective treatment for male pattern baldness, followed by finasteride and minoxidil in various forms and dosages. Users discuss personal experiences, dosages, and potential side effects, with some considering combining treatments for better results.

community FCE 28260: A Forgotten 5α-Reductase Inhibitor

in Research 330 upvotes 3 months ago

FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

community SCUBE3 and GT20029 could be the closet thing to a cure: Hair Follicle Regeneration and Protection Against DHT

in Research/Science 13 upvotes 1 year ago

SCUBE3 and GT20029 are potential treatments for hair loss, with SCUBE3 stimulating hair growth and GT20029 protecting against DHT. A combined approach using SCUBE3, finasteride or dutasteride, and later GT20029 could provide a comprehensive treatment for androgenetic alopecia.

community Research about RU58841 /Why it was stopped

in Research/Science 29 upvotes 3 years ago

RU58841 showed promise for treating androgenic alopecia but research was halted due to financial and organizational changes. There were no significant safety concerns reported in human trials.

community Transient and Permanent Effects of Finasteride Use

in Research/Science 154 upvotes 3 years ago

Potential side effects of 5AR inhibitors like finasteride and dutasteride. Users debate risks, benefits, and personal experiences with these hair loss treatments.

Similar Research

5 / 1000+ results

research Alopecia: Unapproved Treatments or Indications

22 citations, March 2000 in “Clinics in Dermatology”

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

research Consequences of Steroid-5α-Reductase Deficiency and Inhibition in Vertebrates

21 citations, January 2020 in “General and Comparative Endocrinology”

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

research Antiandrogens and Androgen Inhibitors in Dermatologic Treatments

November 2020 in “Elsevier eBooks”

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

research Role of 5α-Reductase in Health and Disease

101 citations, April 1994 in “Baillière's clinical endocrinology and metabolism”

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

research Selections from Current Literature: Androgenetic Alopecia - The Science Behind a New Oral Treatment

2 citations, October 1998 in “Family Practice”

New oral treatment, finasteride, effectively and safely treats common hair loss.